Your browser doesn't support javascript.
loading
Early versus deferred anti-SARS-CoV-2 convalescent plasma in patients admitted for COVID-19: A randomized phase II clinical trial.
Balcells, María Elvira; Rojas, Luis; Le Corre, Nicole; Martínez-Valdebenito, Constanza; Ceballos, María Elena; Ferrés, Marcela; Chang, Mayling; Vizcaya, Cecilia; Mondaca, Sebastián; Huete, Álvaro; Castro, Ricardo; Sarmiento, Mauricio; Villarroel, Luis; Pizarro, Alejandra; Ross, Patricio; Santander, Jaime; Lara, Bárbara; Ferrada, Marcela; Vargas-Salas, Sergio; Beltrán-Pavez, Carolina; Soto-Rifo, Ricardo; Valiente-Echeverría, Fernando; Caglevic, Christian; Mahave, Mauricio; Selman, Carolina; Gazitúa, Raimundo; Briones, José Luis; Villarroel-Espindola, Franz; Balmaceda, Carlos; Espinoza, Manuel A; Pereira, Jaime; Nervi, Bruno.
Afiliação
  • Balcells ME; Department of Infectious Diseases, School of Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile.
  • Rojas L; Department of Internal Medicine, School of Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile.
  • Le Corre N; Program of Pharmacology and Toxicology, School of Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile.
  • Martínez-Valdebenito C; Department of Pediatric Infectious Diseases and Immunology, School of Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile.
  • Ceballos ME; Diagnostic Virology Laboratory, Red de Salud UC CHRISTUS, Santiago, Chile.
  • Ferrés M; Department of Pediatric Infectious Diseases and Immunology, School of Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile.
  • Chang M; Diagnostic Virology Laboratory, Red de Salud UC CHRISTUS, Santiago, Chile.
  • Vizcaya C; Department of Infectious Diseases, School of Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile.
  • Mondaca S; Department of Pediatric Infectious Diseases and Immunology, School of Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile.
  • Huete Á; Diagnostic Virology Laboratory, Red de Salud UC CHRISTUS, Santiago, Chile.
  • Castro R; Department of Hematology and Oncology, School of Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile.
  • Sarmiento M; Department of Pediatric Infectious Diseases and Immunology, School of Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile.
  • Villarroel L; Department of Hematology and Oncology, School of Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile.
  • Pizarro A; Department of Radiology, School of Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile.
  • Ross P; Department of Intensive Care Medicine, School of Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile.
  • Santander J; Department of Hematology and Oncology, School of Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile.
  • Lara B; Department of Public Health, School of Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile.
  • Ferrada M; Department of Infectious Diseases, School of Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile.
  • Vargas-Salas S; Department of Internal Medicine, School of Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile.
  • Beltrán-Pavez C; Department of Psychiatry, School of Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile.
  • Soto-Rifo R; Emergency Medicine Section, School of Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile.
  • Valiente-Echeverría F; Clinical Research Center, School of Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile.
  • Caglevic C; Department of Hematology and Oncology, School of Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile.
  • Mahave M; Laboratory of Molecular and Cellular Virology, Virology Program, Institute of Biomedical Sciences, Faculty of Medicine, Universidad de Chile, Santiago, Chile.
  • Selman C; HIV/AIDS Work Group, Faculty of Medicine, Universidad de Chile, Santiago, Chile.
  • Gazitúa R; Laboratory of Molecular and Cellular Virology, Virology Program, Institute of Biomedical Sciences, Faculty of Medicine, Universidad de Chile, Santiago, Chile.
  • Briones JL; HIV/AIDS Work Group, Faculty of Medicine, Universidad de Chile, Santiago, Chile.
  • Villarroel-Espindola F; Laboratory of Molecular and Cellular Virology, Virology Program, Institute of Biomedical Sciences, Faculty of Medicine, Universidad de Chile, Santiago, Chile.
  • Balmaceda C; HIV/AIDS Work Group, Faculty of Medicine, Universidad de Chile, Santiago, Chile.
  • Espinoza MA; Instituto Oncológico Fundación Arturo López Pérez, Santiago, Chile.
  • Pereira J; Instituto Oncológico Fundación Arturo López Pérez, Santiago, Chile.
  • Nervi B; Instituto Oncológico Fundación Arturo López Pérez, Santiago, Chile.
PLoS Med ; 18(3): e1003415, 2021 03.
Article em En | MEDLINE | ID: mdl-33657114
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Intervenção Médica Precoce / Tempo para o Tratamento / COVID-19 Tipo de estudo: Clinical_trials / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged País/Região como assunto: America do sul / Chile Idioma: En Revista: PLoS Med Assunto da revista: MEDICINA Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Chile País de publicação: Estados Unidos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Intervenção Médica Precoce / Tempo para o Tratamento / COVID-19 Tipo de estudo: Clinical_trials / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged País/Região como assunto: America do sul / Chile Idioma: En Revista: PLoS Med Assunto da revista: MEDICINA Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Chile País de publicação: Estados Unidos